CRP and migraine disorder: In contrast to these, CRP, a general inflammation marker, did not emerge as clearly useful in short-term prediction; changes in hs-CRP did not track well with migraine improvement in a 12-week trial[1], though CRP was elevated in migraineurs at baseline.